Equine Health Market Size, Share & COVID-19 Impact Analysis, By Product (Drug Class, {Anti-Infective, Anti-Inflammatory, Parasiticides, and Others}, Vaccines {Inactivated, Live Attenuated, Recombinant, and Others}, and Supplemental Feed Additives), By Disease Type (West Nile Virus, Equine Rabies, Equine Influenza, Equine Herpes Virus, Potomac Horse Fever, Tetanus, and Others), By Distribution Channel (Veterinary Hospitals And Clinics, Retail Pharmacies and Drug Stores, and Others), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI101416

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 6.7% from 2023-2030
Unit	Value (USD Billion)
Segmentation	By Product Drug Class Anti-Infective Anti-Inflammatory Parasiticides Others Vaccines Inactivated Live Attenuated Recombinant Others Supplemental Feed Additives By Disease Type West Nile Virus Equine Rabies Equine Influenza Equine Herpes Virus Potomac Horse Fever Tetanus Others By Distribution Channel Veterinary Hospitals and Clinics Retail Pharmacies and Drug Stores Others By Region North America (By Product, Disease Type, Distribution Channel, and Country) U.S. Canada Europe (By Product, Disease Type, Distribution Channel, and Country/Sub-Region) Germany U.K. France Italy Spain Scandinavia Rest of Europe Asia Pacific (By Product, Disease Type, Distribution Channel, and Country/Sub-Region) China India Japan Australia Southeast Asia Rest of Asia Pacific Latin America (By Product, Disease Type, Distribution Channel, and Country/Sub-Region) Brazil Mexico Rest of Latin America Middle East & Africa (By Product, Disease Type, Distribution Channel, and Country/Sub-Region) GCC South Africa Rest of the Middle East & Africa